2026-09-20T12:08:34Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/421542022-01-13T07:54:33Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023
Mark Keegan and Darrell J. Irvine.
King, Connie Hong-Yee
Massachusetts Institute of Technology. Dept. of Materials Science and Engineering.
Massachusetts Institute of Technology. Department of Materials Science and Engineering
2008-09-03T14:44:38Z
2008-09-03T14:44:38Z
2007
http://hdl.handle.net/1721.1/42154
228504392
Thesis (M. Eng.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2007.
"September 2007."
Includes bibliographical references (p. 67-72).
As the number of individuals suffering from tissue loss and end-stage organ failure continues to grow, researchers are turning to tissue engineering to provide better methods of treatment. The field, however, still faces many technical challenges that are limiting its applications. One challenge faced in engineering more complex tissues and organs is the need for inherent microvasculature to supply the tissue with nutrients and oxygen. Researchers at The Charles Stark Draper Laboratory have developed a method for engineering microvascular networks in vitro using various microfabrication techniques. This paper discusses the current state of the research and technical challenges to overcome before commercializing the technology. The feasibility of using the networks in the nearer term application of treating chronic wounds will also be assessed, and a potential business strategy will be laid out.
by Connie Hong-Yee King.
M.Eng.
72 p.
eng
Massachusetts Institute of Technology
M.I.T. theses are protected by
copyright. They may be viewed from this source for any purpose, but
reproduction or distribution in any format is prohibited without written
permission. See provided URL for inquiries about permission.
http://dspace.mit.edu/handle/1721.1/7582
Materials Science and Engineering.
Assessment of in vitro engineered microvascular networks and their application in the treatment of chronic wounds
Thesis
application/pdf
false
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="8cef8dcf-23f3-466e-a311-a5dfd29e52e1">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>Assessment of in vitro engineered microvascular networks and their application in the treatment of chronic wounds</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2007</PublicationDate>
<Authors>
<Author>
<DisplayName>King, Connie Hong-Yee</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Materials Science and Engineering.</Keyword>
<Abstract>As the number of individuals suffering from tissue loss and end-stage organ failure continues to grow, researchers are turning to tissue engineering to provide better methods of treatment. The field, however, still faces many technical challenges that are limiting its applications. One challenge faced in engineering more complex tissues and organs is the need for inherent microvasculature to supply the tissue with nutrients and oxygen. Researchers at The Charles Stark Draper Laboratory have developed a method for engineering microvascular networks in vitro using various microfabrication techniques. This paper discusses the current state of the research and technical challenges to overcome before commercializing the technology. The feasibility of using the networks in the nearer term application of treating chronic wounds will also be assessed, and a potential business strategy will be laid out.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>